Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Following closely! However, the stock manipulation and the Nielsen angle is very troubling. Best case scenario is an acquisition and reduced charges. IMO risk is equal to a lottery ticket at this point.
993 is an air cooled Porsche 911. One of the most desirable right now. Good examples are going for low 6 figures... chump change for a con artist...cough cough....alleged.....
That’s what I’ve been doing..almost 300% today...lol...only a couple hundred bucks but what the heck
I agree, if he was explicitly notified to stop promoting the test and they continued to do it anyway they’re done! However, America is the land of second chances and before this story ends up on American Greed it wouldn’t surprise me to see an ace up his sleeve....That’s if he doesn’t take his 993 off a cliff...
Just listening to the video reporting it’s as if they’ve already convicted him....JS
So....you’re saying they have a chance.....whew....lol..,
I agree...There’s a tremendous opportunity if OvaDx can ever get to market. Unfortunately we’re on a wing and a prayer at this point.
If true that explains a lot....hmmmm
If ARYC’s Covid-19 test has any efficacy it will gain traction regardless of where it’s trading. The FDA is in an unprecedented time in history. Regardless of the size of the company, management, lack of financial disclosure if you have anything that will help in this pandemic IMO fortunes will change. Ever the optimist I still believe there’s a very slight chance they could get through this. I’ll just stand here while you get your rotten fruit to throw at me....;(
The only test claims that really matter are the ones put forth from the company. What random shareholders say on a message board may be construed as artificially trying to inflate the share price but that doesn’t incriminate the company unless it’s proven those people posting are in fact employees of said company. I see a lot of fluff and puff in your accusations. The damage here has been done. From .029 to .0001 practically overnight. Now it’s up to Arrayit to either repair it’s public image (which I believe it’s trying to do) or wither away like so many real pump and dump schemes. TBH only time will tell. For most of us we’re going to ride out. If that means bankruptcy so be it. If that means up listing and multiple dollars per share so be it. Everything else is poppycock!
This may answer your question.
Cole Business Development LLC (Louisiana LLC) operates within a Master Services Agreement with Arrayit Corporation, Sunnyvale California for State Licensed, CLIA certified clinical testing services.
Registrations of Federal, State Government and all properly licensed healthcare providers are provided through Arrayit Corporation partner Patient Data Solutions.
Thanks for sharing this....”AuthorizedH”....For some of us this still has a lot potential. For that reason alone it’s worth a punt.
Hey TravO, did you have to call in?
Whoever bought at .0001 this morning is looking pretty smart. Now at .0098....
I’ll buy a few million at .0001 what the heck
With 305k shares traded at the open
It’s showing .0001
What serology tests are being offered under the policy outlined in section IV.D of the Policy of Diagnostic tests?
A: As stated in Section IV.D of the FDA's Policy for Diagnostic Tests for Coronavirus Disease-2019, the FDA does not intend to object to the development and distribution by commercial manufacturers, or development and use by laboratories, of serology tests to identify antibodies to SARS-CoV-2, where the test has been validated, notification is provided to FDA, and information along the lines of the following is included in the test reports:
This test has not been reviewed by the FDA.
Negative results do not rule out SARS-CoV-2 infection, particularly in those who have been in contact with the virus. Follow-up testing with a molecular diagnostic should be considered to rule out infection in these individuals.
Results from antibody testing should not be used as the sole basis to diagnose or exclude SARS-CoV-2 infection or to inform infection status.
Positive results may be due to past or present infection with non-SARS-CoV-2 coronavirus strains, such as coronavirus HKU1, NL63, OC43, or 229E.
To help ensure the above information is provided in the test report, as described in the guidance, commercial manufacturers could include this information in their Instructions for Use (IFU) or other labeling provided to laboratories.
This policy does not apply to at home testing.
The commercial manufacturers and laboratories in the two lists below have notified FDA that they have validated and are offering serology tests as set forth in Section IV.D of the FDA's Policy for Diagnostic Tests for Coronavirus Disease-2019. Unless an Emergency Use Authorization (EUA) has also been submitted and reviewed, the FDA has not reviewed the validation of tests offered by these developers, who may not be pursuing EUAs. FDA is including this list here to provide transparency regarding the notifications submitted to FDA.
Laboratories that have notified FDA that they have validated and are offering serology tests as set forth in Section IV.D:
Where the Authorization Status is "FDA Authorized," the FDA reviewed and issued an EUA for the test after notification was given. Where the Authorization Status is shown as "Not FDA Authorized," the FDA has not yet reviewed the laboratory's validation and issued an EUA for the laboratory's test, and the test is included in this list to provide transparency regarding the notifications submitted to FDA. The "Setting for Use" designation of "H" refers to a laboratory certified under CLIA to perform high-complexity testing.
Search:
Laboratory Authorization Status Settings for Use1
Access Medical Laboratories Not FDA Authorized H
Arrayit Corporation Not FDA Authorized H
Beaumont Health Not FDA Authorized H
BioDiagnostic Labs LLC Not FDA Authorized H
Bioreference Laboratories Inc. Not FDA Authorized H
Boston Heart Diagnostics Not FDA Authorized H
DLS Research & Ventures Not FDA Authorized H
EDP Biotech Corporation Not FDA Authorized H
Emory Medical Laboratories Not FDA Authorized H
HealthQuest Esoterics Not FDA Authorized H
IMMYLabs Not FDA Authorized H
Lenco Diagnostic Laboratory Not FDA Authorized H
Mayo Clinic Not FDA Authorized H
Michigan Health Clinics Not FDA Authorized H
Otogenetics Not FDA Authorized H
Roseland Community Hospital/American Medical Lab Not FDA Authorized H
University of Minnesota Advanced Research and Diagnostic Laboratory Not FDA Authorized H
US Specialty Labs Not FDA Authorized H
Vibrant America Clinical Labs Not FDA Authorized H
Showing 1 to 19 of 19 entries
Ok, silly me...where does it say expired? Thanks I see the date of 4/18/20 but I don’t see expired...apologies in advance...maybe I’m just not seeing it.
Re: How much are the Covid tests?
Dear Valued Customer, We received more than 50,000 requests for our finger stick blood test for SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19). Our team is coordinating with local, state and federal agencies and with our distributors to make this test available to as many patients as possible on an expedited timeline. Please consult our website and press releases for updates.
Best regards,
Arrayit Corporation
Very well said... I concur...
LOL....A little brevity among the chaos.
Wow! What a $h1 t show! It’s looking more and more like “shoot first and ask questions later”.
However, when you’ve got DC’s administering allergy/COVID-19 tests it’s certainly gone to far. Form 15 was no shield from the SEC.
What is the likelihood the SEC reverses their decision? Pretty slim....
There are a lot of people with a million or more shares here. The CEO needs to come out and at least say they are cooperating with all authorities and will file financials within the 10 day process. The board has taken a huge hit here too. I think Mark had like 70 million shares alone.
Yes, it looks like I stumbled into a quagmire of my own making.
If anything good comes out of this it’s that they will be forced to provide financials. However, and unfortunately it Will open on the Grey sheet for trading. My take is it won’t be pretty. Silver lining maybe that if they get current (only 2 prior years of financial statements) and can prove no fraud there would be a chance to trade on a higher exchange. But, that would take time months maybe years. All of this was so unnecessary.... A broker friend of mine wanted to invest but kept saying I’ll buy when the CE has lifted. That was 3 years ago....There is a slight chance the company can make it but they need to get there act together quickly.
Stocks generally end up as what is commonly called Grey Sheet stocks after an SEC suspension. Technically, it is the Grey Market.
Market Makers are warned, pursuant to 15c 211 not to publish a quote for the security without reviewing its information statement/clarified information statement
Other OTC or otherwise known as the "GREY Market" is the trading of a security that is not listed on any stock exchange or quoted on the Pink Sheets or the OTCBB.
Other OTC trades are however reported to the NASD so investors can still track price and volume, however bids and offers are not collected in a central spot so Best Execution of orders is difficult.
As of September 21, 2012: From January 2010 until today there have been a total of 1116 SEC Suspensions where ALL 1116 stocks were reinstated on the Grey Sheets after the ten day SEC Suspension ended.
Of the 1116 SEC Suspended stocks since January 2010 645 Registrations have been revoked.
The remaining 471 stocks are on the Grey Sheets (or still in the ten day SEC Suspension within the last ten days) and not one has made it off the Grey Sheets back to quotation by any Market Maker.
Of the 471 stocks that are on the Grey Sheets most are awaiting revocation on DEFAULT for failure to file Financials, wherein there were no other allegations that would require subsequent SEC Litigation(s).
Stocks that were Suspended for any allegations are awaiting SEC Litigation or are being litigated and those stocks will remain on the Grey Sheets and will NOT be revoked until all SEC Litigation has been adjudicated by an SEC Administrative Law Judge.
For additional research the links below comprise all SEC Actions back to 1995.
SEC Suspensions:
http://www.sec.gov/litigation/suspensions.shtml
SEC Administrative Proceedings:
http://www.sec.gov/litigation/admin.shtml
SEC Litigations:
http://www.sec.gov/litigation/litreleases.shtml
Administrative Law Judge Orders:
http://www.sec.gov/alj/aljorders.shtml
Good morning PSA, I wanted to reach out to you as there has been a lot of confusion in the last 24 hours or so. What’s your take if don’t mind taking a few minutes. I trust your thoughts and judgement.
Thanks, Marc
Yes, business rolls on. In my eyes they’ve done nothing wrong. We’ll wait to see if they can get the SEC to agree.
The SEC has the authority to temporarily suspend trading in stocks for 10 days to protect investors if it has concerns about a company or unusual trading activity in its shares. Such suspensions don’t necessarily mean a company has done anything illegal.
“Our test has been validated, notification has been provided to the FDA and warning statements are on each test report. Doctors order the test and doctors make the official diagnosis”.
Luna you have always had a level and reasonable take. If your not concerned I’m not concerned. The truth will set us free. In more ways than one.
Bottom line here is that it’s poop or get off the pot time. I believe they withheld financials for as long as they could in hopes the lawsuits would be resolved. This imo is a net positive for shareholders in that we finally get resolution one way or another. They probably would like to go private but IMO would be a poison pill. If they’ve done nothing wrong and can file we should open in the .30 range. “Worry is the misuse of your imagination”. Time to move forward. We all knew the risk here and chose to invest anyway.
The need for testing is real. ARYC and a handful of others will come out of this a much bigger and better company. This could be a .30 stock a few days from now. The market cap is pricing in almost nothing imo. Drop financials (which I believe they will) drop the CE and you’ll see $$$.... Risk/Reward never been better!
IMO
https://apple.news/ApYBnbEHHQpqvYU7NDZSEaA
One sees what one wants to see...It’s always been easy to arm chair QB from the friendly confines of ones domicile....If you’ve come this far patience and a level head should see you through. IMO Many exciting developments are happening and when the time is right we’ll know....
Utah Valley 360
COVID POSITIVE? HELP US OUT: A biotech company is looking for people who have tested positive for COVID-19 to provide blood test samples for development of a serology test to measure antibody levels. For info, call (408) 744-1331 or visit www.arrayit.com
I agree...ARYC is very limited under Form 15 guidelines. Per SEC if they had 10 mil in assets as of the prior calendar year...120 days from Jan 1st. following year must provide at least two years of financial statements. Someone correct me if I’m wrong...May could make a lot of people who’ve been acquiring shares at these levels very wealthy. IMO